Zelicapavir
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Zelicapavir, covering 2025-07-28 to 2026-03-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus [Phase 2]